Get the Stockscreener App
28.04
0.50%
-0.14
After Hours:
28.04
Atricure Inc stock is traded at $28.04, with a volume of 398.11K.
It is down -0.50% in the last 24 hours and up +6.98% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
See More
Previous Close:
$28.18
Open:
$28.18
24h Volume:
398.11K
Relative Volume:
0.52
Market Cap:
$1.36B
Revenue:
$429.95M
Net Income/Loss:
$-40.12M
P/E Ratio:
-51.93
EPS:
-0.54
Net Cash Flow:
$-19.66M
1W Performance:
-3.48%
1M Performance:
+6.98%
6M Performance:
-7.82%
1Y Performance:
-35.98%
1-Day Range:
$27.93
$29.05
1-Week Range:
$27.93
$30.15
52-Week Range:
$18.94
$43.54
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
United States Left Atrial Appendage (LAA) Closure Market By Application Report 2031 - thirdeyenews.in
AtriCure, Inc. (NASDAQ:ATRC) Shares Acquired by Renaissance Technologies LLC - MarketBeat
Hsbc Holdings PLC Boosts Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Shares Bought by First Light Asset Management LLC - MarketBeat
Structural Heart Imaging Market May Set New Growth Story | Edwards Lifesciences, NuMed, AtriCure, LivaNova - openPR
Hood River Capital Management LLC Takes Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Atrial fibrillation market is poised for substantial growth, with its value projected to rise $3,370.70+ - EIN News
AtriCure Marks First AtriClip FLEX-Mini Treatment - MPO-mag
Atlas Copco (STO:ATCO A) Has Announced A Dividend Of SEK1.40 - Simply Wall St
Atrion (NASDAQ:ATRI) Coverage Initiated at StockNews.com - Defense World
Tapestry (NYSE:TPR) Stock Rating Lowered by StockNews.com - Defense World
AACT stock soars to all-time high of $10.82 amid market optimism - Investing.com Canada
Ares Acquisition Co. II (NYSE:AACT) Sets New 1-Year High at $10.81 - Defense World
An Analysis of Atricure Inc (ATRC)’s Potential Price Growth - Knox Daily
Atlanticus Holdings Co. (NASDAQ:ATLC) Director Sells $78,375.00 in Stock - Defense World
Tapestry Inc [TPR] stock was sold by Dadlani Manesh at the price of US$0.11 million - Knox Daily
Atlanticus Holdings director sells $78,375 in stock - Investing.com
ATA Lands Private Equity Investment From Copley Equity Partners - CPAPracticeAdvisor.com
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - AccessWire
ATN International, Inc. (NASDAQ:ATNI) Short Interest Up 5.2% in August - Defense World
Athira Pharma Inc (NASDAQ: ATHA): Slumped -75.09% In 2024, Outlook Stable - Stocks Register
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug - Benzinga
Here’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) - Insider Monkey
Here’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) - Yahoo Finance
Wall Street Analysts Believe Air Transport Services (ATSG) Could Rally 31.04%: Here's is How to Trade - Yahoo Finance
AptarGroup, Inc. (NYSE:ATR) Short Interest Down 7.0% in August - MarketBeat
Applied Therapeutics Shares Rise as Drug Continues with Priority Review - MarketWatch
A stock that deserves closer examination: Atricure Inc (ATRC) - US Post News
Atmos Energy Co. (NYSE:ATO) Sees Large Decline in Short Interest - MarketBeat
Parallel Advisors LLC Raises Stake in AptarGroup, Inc. (NYSE:ATR) - Defense World
Rhumbline Advisers Cuts Stock Holdings in Atrion Co. (NASDAQ:ATRI) - Defense World
Investor Optimism Abounds Atlas Copco AB (STO:ATCO A) But Growth Is Lacking - Simply Wall St
Atkore Inc. to Attend the 2024 RBC Capital Markets Global Industrials Conference - sharewise
Trading (ATRC) With Integrated Risk Controls - Stock Traders Daily
Trend Tracker for (ATLCP) - Stock Traders Daily
(ATCOL) Technical Pivots with Risk Controls - Stock Traders Daily
ATA scores private equity investment - Accounting Today
Atour Lifestyle Holdings Ltd ADR (ATAT) is looking forward to a strong quarter - SETE News
Prukalpa Sankar on why empathy is her company’s greatest asset - StartupNews.fyi
Daily Market Movement: Atricure Inc (ATRC) Sees a -3.23 Decrease, Closing at 27.30 - The Dwinnex
ATPC’s Stock Journey: What Investors Need to Know About Agape ATP Corp’s Performance - The InvestChronicle
A new trading data show Agape ATP Corp (ATPC) is showing positive returns. - SETE News
Atour Lifestyle Holdings Limited (NASDAQ:ATAT) Short Interest Down 8.3% in August - MarketBeat
Check out these key findings about Atricure Inc (ATRC) - SETE News
Atkore Stock: Stabilization Seems To Arrive (NYSE:ATKR) - Seeking Alpha
Checking in on Atmos Energy Corp. (ATO) after recent insiders movement - Knox Daily
APD sergeant taken to Grady after accidentally shooting his leg while submitting gun into evidence - 11Alive.com WXIA
Atlanta police sergeant accidentally shoots himself, taken to Grady Memorial Hospital - WSB Atlanta
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Yahoo Finance
Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study - AccessWire
Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study - StockTitan
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):